Bengaluru, Feb 21 (IANS) The Karnataka government has sought assistance from the Union Health Minister in countering the menace of sale of drugs which have failed tests and further appealed to ensure steps to withdraw contaminated drugs from market all across India.
Minister for Health Dinesh Gundu Rao wrote a letter on Friday to the Union Health Minister J.P. Nadda in this regard.
“I am writing to bring to your attention the repeated instances of sale within Karnataka of contaminated injectable drugs manufactured in other states.
“Between January 1 and February 16, nine injectable drugs manufactured in other states failed sterility testing in our state government laboratories. The details of drugs, along with batch numbers, are provided in the annexure to this letter,” Minister Rao stated.
This list does not include numerous injectables manufactured by Paschim Banga Pharmaceuticals based in West Bengal, whose contaminated injectables caused the deaths of five young mothers in Ballari district of Karnataka, Rao said.
“While I am instructing my department to take adequate steps to ensure these drugs are no longer sold within Karnataka, it is highly likely that other contaminated drugs manufactured by these companies are being sold in other states in India. Injectables, as you are aware, are used in acute care and therefore are high risk to patients.
“Given the ‘life or death’ consequences for patients being administered these contaminated drugs, I request you to use your good offices to ensure that all products sold by these companies are withdrawn from the market across India and that these companies are not allowed to sell any more drugs until they are inspected by the Central Drugs Standard Control Organisation (CDSCO) for compliance with Good Manufacturing Practices (GMP),” Rao urged.
Minister Rao further requested, “In addition, I also request you to create a system for all states and central laboratories to share alerts with each other regarding drugs which have failed quality testing, especially those failures which could potentially cause serious adverse events for patients.”
He further suggested, “In addition to sharing alerts with each other there should also be a legal requirement to share sales records from the manufacturer to enable seizure of the contaminated drugs from the supply chain before they are dispensed to patients.
“Lastly, we need a system to alert doctors, pharmacists and patients about the drugs that are failing testing in our respective testing laboratories. My department would be glad to assist in this regard.”
Rao has ended the letter stating that he is anticipating a positive response in this regard.
–IANS
mka/rad
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
